Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 4 ( July-August, 2024 ) > List of Articles

Original Article

COVID Immunization Status of Pregnant Patients Delivering in a Tertiary Level Government Hospital in India

Renuka Malik, Bharti Uppal, Namita Chopra, Neha Pruthi

Keywords : Covaxin in pregnancy, Coronavirus disease-2019 in pregnancy, Coronavirus disease-2019 vaccine, Covishield in pregnancy, Immunization in pregnancy

Citation Information : Malik R, Uppal B, Chopra N, Pruthi N. COVID Immunization Status of Pregnant Patients Delivering in a Tertiary Level Government Hospital in India. J South Asian Feder Obs Gynae 2024; 16 (4):350-353.

DOI: 10.5005/jp-journals-10006-2432

License: CC BY-NC 4.0

Published Online: 09-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Immunization is the most effective form of prevention against coronavirus disease-2019 (COVID-19) related complications during pregnancy. This study was done to see the prevalence of the COVID-19 immunization status in pregnant women delivering in a tertiary level Government Hospital in New Delhi, India, and associated side effects of COVID vaccine in pregnancy. Materials and methods: A prospective cross-sectional study was conducted from 1st July 2022 to 31st December 2022 in a tertiary level, Government Hospital in New Delhi, India. The Institutional Ethical Committee provided approval for the study. A written questionnaire was given to all consecutive pregnant women delivering in the hospital, after taking written consent and details of COVID vaccine, number of doses, time of immunization (antenatal/postpartum), COVID infection status (antenatal/postnatal period) and adverse reactions encountered. Observation and results: Women (842) were included in the study, out of which 87% (605/842) were vaccinated and 12.6% (218/842) were unvaccinated. The majority (70.4%) received Covishield while 29.6% received Covaxin. Adverse effect following vaccination was experienced by 9.2% (68/842) women and was mild. Conclusion: The total vaccine coverage among the women enrolled in the study was 87%. There was no statistically significant difference (p-value = 0.095) in the side effects profile of the Covaxin and Covishield vaccines. Among the hesitancy factors observed in the unvaccinated group, safety concern regarding vaccines was the most dominant factor.


HTML PDF Share
  1. Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of COVID-19 vaccines in ambulatory and inpatient care settings. N Engl J Med 2021;385(15):1355–1371. DOI: 10.1056/NEJMoa2110362.
  2. Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet 2021;397(10287):1819–1829. DOI: 10.1016/S0140-6736(21)00947-8.
  3. Ioannou GN, Locke ER, O'Hare AM, et al. COVID-19 vaccination effectiveness against infection or death in a national U.S. health care system: A target trial emulation study. Ann Intern Med 2022;175(3):352–361. DOI: 10.7326/M21-3256.
  4. Singh S, Sharma A, Gupta A, et al. Demographic comparison of the first, second and third waves of COVID-19 in a tertiary care hospital at Jaipur, India. Lung India 2022;39(6):525–531. DOI: 10.4103/lungindia.lungindia_265_22.
  5. Thakkarwad S, Asalkar M, Sharma N. Maternal COVID-19 infection and perinatal outcome in three waves of COVID pandemic: A cross-sectional study. J South Asian Feder Obs Gynae 2023;15(3):297–303. DOI: 10.5005/jp-journals-10006-2225.
  6. Ministry of Health and Family Welfare Government of India. COVID-19 vaccines-operational guidelines. Available at: www.mohfw.gov.in.
  7. Naqvi S, Saleem S, Naqvi F, et al. Knowledge, attitudes, and practices of pregnant women regarding COVID-19 vaccination in pregnancy in 7 low- and middle-income countries: An observational trial from the Global Network for Women and Children's Health Research. BJOG 2022;129(12):2002–2009. DOI: 10.1111/1471-0528.17226.
  8. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: A multinational, observational study 2023;401. Available at: www.thelancet.com.
  9. Garg R, Lal P, Agrawal P, et al. Menstrual cycle changes after COVID-19 infection: Does coronavirus-induced stress lead to hormonal change? J South Asian Feder Obst Gynae 2022;14(3):248–252. DOI: 10.5005/jp-journals-10006-2027.
  10. Garg R, Agarwal R, Yadav D, et al. Histopathological changes in placenta of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and maternal and perinatal outcome in COVID-19. J Obstet Gynecol India 2023;73:44–50. DOI: 10.1007/s13224-022-01666-3.
  11. Malhotra J, Agrawal P, Garg R, et al. Corona virus disease (COVID-19) and pregnancy: What obstetricians should know. J South Asian Feder Obst Gynae 2019;11(6):337–339. DOI: 10.5005/jp-journals-10006- 1744.
  12. Agarwal N, Garg R, Singh S, et al. Coronavirus disease 2019 in pregnancy: Maternal and perinatal outcome. J Educ Health Promot 2021;10(1):194. DOI: 10.4103/jehp.jehp_954_20.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.